Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$510.68 - $643.45 $16,341 - $20,590
-32 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$454.43 - $535.6 $2,272 - $2,678
5 Added 18.52%
32 $15,000
Q2 2020

Aug 14, 2020

SELL
$334.87 - $493.06 $794,646 - $1.17 Million
-2,373 Reduced 98.88%
27 $11,000
Q4 2019

Feb 12, 2020

BUY
$319.73 - $374.2 $767,352 - $898,080
2,400 New
2,400 $888,000
Q4 2017

Feb 15, 2018

SELL
$216.94 - $271.3 $120,184 - $150,300
-554 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$212.27 - $242.28 $117,597 - $134,223
554
554 $0

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.17B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.